Alicia Secor

Alicia Secor, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in GW Pharmaceuticals PLC, Juniper Pharmaceuticals Inc and G1 Therapeutics, Inc. The record holds 25 filings, for trades running from 19 June 2014 to 18 September 2024.

Market trades split into 2 purchases (€84k) and 5 sales (€978k). Sales outweigh purchases by €894k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 10 share grants and 4 option exercises.

On 18 September 2024 came the latest disclosure, a transaction in G1 Therapeutics, Inc. The last purchase on record was published on 29 August 2016, which is 3,707 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.